MAPT and Alzheimer disease: Cytotoxicity-based pathological mechanisms have been acknowledged to account for several neurodegenerative diseases, such as Alzheimer’s disease, in which pathological aggregations of the tau protein are recognized as one of the hallmarks of the diseases [124], with over 100 dominantly inherited tau variants reported to date.